|
|
|
|
|
|
The latest Alzheimer's disease news from News Medical
|
|
|
|
|
Sponsored by Acro Biosystems |
|
|
| Alzheimer's Disease news stories from News Medical... |
|
|
|
Focusing on Alzheimer’s Disease Patients
Alzheimer’s disease (AD) is still pervasive across the world, affecting millions of people each year.
Aneuro, from ACROBiosystems, is committed to providing innovative life science tools and solutions to AD researchers to help accelerate the entire drug development process, from discovery to commercialization.
|
|
|
|
|
|
Abnormal electrical activity in the brain of people with Alzheimer's leads to epileptic seizures
Alzheimer's disease causes death of neurons, and researchers hypothesize this may contribute to abnormal electrical activity in the brain that leads to epileptic seizures.
|
|
UCSF dementia experts to join peers at annual Clinical Trials on Alzheimer's disease conference
Dementia experts from UC San Francisco will join their peers from around the globe at the annual Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston from Oct. 24 to 27.
|
|
|
|
| Alzheimer's Disease articles from News Medical... |
|
|
|
Pre-formed Fibrils (PFFs): Another Perspective for Disease Modeling
Excessive buildup of tau and alpha-synuclein, which can spread prion-like and form aggregates, ultimately triggers neurodegenerative conditions like AD. Using their own bioactive Tau PFFs and Alpha-Synuclein PFFs, ACRO aims to provide researchers with a different type of disease model that could help accelerate AD and PD research and drug development.
|
|
|
|
|
|
Identifying a signature biomarker for early-onset Alzheimer's disease
Alexandra Touroutoglou, PhD, and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts General Hospital, are the lead authors of a new study published in Alzheimer's & Dementia, The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy.
|
|
Is COVID-19 a risk factor for Alzheimer's disease?
The study explores the interconnected risks between COVID-19 and Alzheimer's Disease (AD), highlighting how SARS-CoV-2 can aggravate AD pathology through neuroinflammation and neurodegeneration. It raises significant concerns about the long-term cognitive implications of COVID-19, especially among those already at risk for AD.
|
|
|
|
| More Alzheimer's Disease stories from News Medical... |
|
|
|
Neural Factors: Supplying and Maintaining Nerve Cells
In Alzheimer's disease, neural elements, such as glial cell line-derived neurotrophic factor (GDNF), have shown promise in shielding dopaminergic neurons from degeneration and enhancing their viability in preclinical investigations. ACROBiosystems offers a range of tailored recombinant neural factor proteins to aid nerve cell culture and differentiation.
|
|
|
|
|
|
Can Beta-carotene boost cognitive health? Study reveals promising insights
A systematic review explores the potential of β-carotene in enhancing cognitive function, revealing its potential benefits and the importance of dietary interventions for cognitive health.
|
|
DASH diet may help preserve cognitive function in women later in life
Women with diets during middle age designed to lower blood pressure were about 17 percent less likely to report memory loss and other signs of cognitive decline decades later, a new study finds.
|
|
|
|
